To direct the Comptroller General of the United States to conduct a study to investigate the feasibility of establishing user fees to offset certain Federal costs attributable to the procurement of single-source materials for the Strategic National Stockpile, and for other purposes.

Bill: 116-hr-6875
Sponsor: full_name: Rep. Slotkin, Elissa [D-MI-8]
Introduced: 2020-05-14
Policy area: Health
Subjects: Congressional oversight

Emergency medical services and trauma care

Government Operations and Politics

Government studies and investigations

Health technology, devices, supplies

Public contracts and procurement

Strategic materials and reserves

User charges and fees
Latest action: action_date: 2020-05-14
text: Referred to the House Committee on Energy and Commerce.

Summaries:
action_date: 2020-05-14
action_desc: Introduced in House
text: <p>This bill requires the Government Accountability Office to study the feasibility of assessing user fees to offset federal costs associated with single-source materials for which the Strategic National Stockpile is the sole provider (e.g., certain antitoxins). </p> <p>The study must address whether health care providers or other entities that receive such materials generate profits when charging patients for them.</p>

tv_txt: I 116th CONGRESS 2d Session H. R. 6875 IN THE HOUSE OF REPRESENTATIVES May 14, 2020 Ms. Slotkin (for herself and Mr. Van Drew ) introduced the following bill; which was referred to the Committee on Energy and Commerce A BILL To direct the Comptroller General of the United States to conduct a study to investigate the feasibility of establishing user fees to offset certain Federal costs attributable to the procurement of single-source materials for the Strategic National Stockpile, and for other purposes.

1. GAO study on the feasibility and benefits of a Strategic National Stockpile user fee agreement (a) In general The Comptroller General of the United States shall conduct a study to investigate the feasibility of establishing user fees to offset certain Federal costs attributable to the procurement of single-source materials for the Strategic National Stockpile under section 319F–2 of the Public Health Service Act ( 42 U.S.C. 247d–6b ) and distributions of such materials from the Stockpile. In conducting this study, the Comptroller General shall consider, to the extent information is available— (1) whether entities receiving such distributions generate profits from those distributions; (2) any Federal costs attributable to such distributions; (3) whether such user fees would provide the Secretary with funding to potentially offset procurement costs of such materials for the Strategic National Stockpile; and (4) any other issues the Comptroller General identifies as relevant. (b) Report Not later than February 1, 2023, the Comptroller General of the United States shall submit to the Congress a report on the findings and conclusions of the study under subsection (a).